Concepedia

Hans-Bernd Prisack

HP

Statistics

Publications

5

Citations

280

H-Index

5

Active since

2004

Affiliations

Heinrich Heine University Düsseldorf(Current)

Bayer (Germany)

Hans-Bernd Prisack is an author at Heinrich Heine University Düsseldorf specializing in oncology, molecular tumor profiling, and cancer biomarkers.

Publications per year

2004–2023

5

Publications

5

Identifying Superficial, Muscle-Invasive, and Metastasizing Transitional Cell Carcinoma of the Bladder

Olga Modlich, Hans-Bernd Prisack, Gerald Pitschke et al. · Clinical Cancer Research · 2004 · 108 citations

Medicine, Oncology, Urology +17

Immediate Gene Expression Changes After the First Course of Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Disease

Olga Modlich, Hans-Bernd Prisack, Marc Munnes et al. · Clinical Cancer Research · 2004 · 64 citations

Life Sciences, Cancer Biology, Oncology +17

Predictors of primary breast cancers responsiveness to preoperative Epirubicin/Cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

Olga Modlich, Hans-Bernd Prisack, Marc Munnes et al. · Journal of Translational Medicine · 2005 · 51 citations · Full text

Medicine, Biostatistics, Oncology +16

Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapy.

Hans-Bernd Prisack, Christiaan Karreman, Olga Modlich et al. · PubMed · 2006 · 42 citations

Medicine, Oncology, Breast Oncology +16

Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer

Julia Karbach, Dragan Kiselicki, Kathrin Brand et al. · Journal for ImmunoTherapy of Cancer · 2023 · 15 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 5